M-Brain is now Valona in Global Rebrand
M-Brain, a global forerunner of competitive and market intelligence solutions, will evolve into Valona Intelligence. This powerful new identity leverages the company’s 20 years of experience, reflecting its position as a world leader in the Market and Competitive Intelligence space.
Valona’s hybrid intelligence approach uses AI at the core to provide impactful insights from over 200,000 business-focused global content sources, including those behind paywalls. Combining their proprietary AI technology with a team of industry-savvy analysts and customer strategists at the helm, Valona equips businesses with the tools needed to make impactful, informed decisions.
"Under the new identity of Valona, we're elevating market and competitive intelligence beyond generative AI," said Kimmo Havu, CEO at Valona. "By integrating AI with authentic, reliable content, alongside human analysis, we bridge the gap between raw data and actionable insights that fuel business decisions."
This distinctive blend equips Valona customers with a measurable competitive edge while enhancing their ability to identify market trends early.
"In contrast to many market competitors who are pure technology providers, we ensure our customers have comprehensive support,” Havu said. “Our toolkit, backed with our team's expertise, operationalizes insights to strategically target business needs, ensuring our customers stay ahead of their competition.”
"Our commitment to our customers goes beyond facilitating better decisions; we drive revenue growth. After all, what is greater than gaining more customers?” Havu said.
Valona continues to invest in its vision to make every business decision insights-driven at all levels of an organization. The introduction of a unique AI research assistant to the platform is further evidence of Valona’s commitment to maintaining its cutting-edge status. This new feature, launching later this year, will amplify organizations’ ability to perform faster, more precise analyses – just one highlight of the forward-thinking investments under the company’s renamed identity.
The rebrand underlines Valona’s status as a market leader, a recognition backed by The Forrester WaveTM: Market and Competitive Intelligence Platforms, Q2 2023 report. With an exceptional track record and a platform tailored for the future, Valona is set to redefine market and competitive intelligence.
About Valona
Valona Intelligence is the recognized leader in the market and competitive intelligence since 1999, formerly known as M-Brain. Combining the power of generative AI and analyst expertise, Valona provides businesses with the most crucial insights and to enable insights-driven decisions. Valona sends over 200,000 news alerts serving over 350,000 business users every day, with insights from hundreds of thousands of trusted industry-specific sources globally in over 100 languages. All translated into clean business summaries in English and presented in clear formats easy to share.
Having a global team across 9 offices in Americas, Europe, and Asia, Valona provides leading Fortune 500 with foresight to shape the future resulting in real business growth. Companies like Goodyear, Inspire Brands, Bosch, Philips, and Cintas have trusted M-Brain as their market intelligence solution, service, and content provider. Valona is acknowledged by Forrester in 2023 as the premier global platform for market and competitive intelligence. Discover more at www.valonaintelligence.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230912678029/en/
Contact information
Kati Tammisto
CMO, Valona
Kati.tammisto@valonaintelligence.com
+358 40 775 7162
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Despite Continued Economic Volatility, Global Financial Inclusion Improved According to the Global Financial Inclusion Index from Principal ®3.10.2023 07:01:00 CEST | Press release
Singapore is the world’s most financially inclusive market across 42 analyzed, alongside Hong Kong, Switzerland, the United States, and Sweden, according to the second edition of the Global Financial Inclusion Index (the Index) from Principal Financial Group®. The research released today, conducted by the Centre for Economics and Business Research (Cebr) and Principal®, examines how well a market’s respective government, financial system, and employers provide relevant tools, services, and guidance to enable greater levels of financial inclusion. Now in its second year, the report provides a comprehensive and comparative evaluation of financial inclusion on a global scale – ranking 42 markets on a relative basis in addition to a new absolute score assigned at the global and regional levels. This enables the identification and analysis of regions making the most progress and those facing the greatest challenges. “Despite the uncertain economic conditions of the past year, it’s encouragi
ARMA Instruments Launch Zero Trust G1 Mark II Secure Messaging Communication Device3.10.2023 05:00:00 CEST | Press release
The Russian invasion of Ukraine has ignited an arms race in the theater of cyber warfare. Zero trust is the operative term for military, defense sectors, and governments across the globe. U.S. intelligence agencies and international partners recently published a report warning of the new Russian malware program Sandworm, likely targeting Ukrainian interests in its ongoing war, and U.S. defense agencies set a deadline of 2027 for implementation of zero trust cybersecurity environments [FedTech, August 2023]. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231002887540/en/ Switzerland-based ARMA Instruments AG announces the launch of their ARMA G1 Mark II Secure Messaging Device. Developed with zero trust principles, the device is a closed mobile system for person-to-person messaging at the highest security levels to counter advanced adversary attacks. The device will be beneficial for NGOs, defense agencies, cybersecurity oper
SLB Launches Carbon Storage Screening and Ranking Solution3.10.2023 04:00:00 CEST | Press release
SLB (NYSE: SLB) today launched its carbon storage screening and ranking solution that increases confidence in site selection decisions based on scientific analysis of the long-term integrity and economic potential of an asset. The solution helps customers avoid suboptimal storage sites with risk factors that can waste valuable time and resources as well as decrease the probability of a carbon capture, utilization and storage (CCUS) project reaching final investment decision (FID). “CCUS is one of the most immediate opportunities to reduce emissions, but it must scale up by 100–200 times in less than three decades to have the expected impact on global net zero ambitions,” said Frederik Majkut, senior vice president of Carbon Solutions for SLB’s New Energy business. “Ensuring that a storage site is both safer and economical is crucial for the speed, scale and investment needed to meaningfully drive CCUS growth for a low carbon energy ecosystem.” The screening and ranking solution uses bo
Takeda Provides Update on EXKIVITY ® (mobocertinib)2.10.2023 22:30:00 CEST | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that, following discussions with the U.S. Food and Drug Administration (FDA), it will be working with the FDA towards a voluntary withdrawal of EXKIVITY® (mobocertinib) in the U.S. for adult patients with epidermal growth factor receptor (EGFR) Exon20 insertion mutation-positive (insertion+) locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on or after platinum-based chemotherapy. Takeda intends to similarly initiate voluntary withdrawal globally where EXKIVITY is approved and is working with regulators in other countries where it is currently available on next steps. This decision was based on the outcome of the Phase 3 EXCLAIM-2 confirmatory trial, which did not meet its primary endpoint and thus did not fulfill the confirmatory data requirements of the Accelerated Approval granted by the U.S. FDA nor the conditional marketing approvals granted in other countries. The EXCLAIM-2 trial was a Phase 3
Galderma announces progress with RelabotulinumtoxinA regulatory submissions2.10.2023 22:27:00 CEST | Press release
Galderma, the emerging pure-play dermatology category leader, announced today updates related to the regulatory progress of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA (QM-1114) to the U.S. Food and Drug Administration (“FDA”). The FDA has issued a Complete Response Letter (“CRL”) to Galderma related to its BLA for RelabotulinumtoxinA for the treatment of moderate-to-severe glabellar lines (frown lines) associated with corrugator and/or procerus muscle activity in adult patients as well as moderate-to-severe lateral canthal lines (crow’s feet) associated with orbicularis oculi muscle activity in adult patients. The CRL points out certain deficiencies isolated to items related to Chemistry, Manufacturing, and Controls (“CMC”) processes. All other aspects of the BLA, including safety and efficacy related parts, did not solicit deficiencies to be addressed. Galderma has already identified changes to the manufacturing process to address feedback. It will also